Capital Flows
FDA Approves First Drug for Alexander Disease
FDA approves Zanvastro for Alexander disease, the first treatment targeting the root cause of this rare neurological disorder.
By Wulan Safitri · Sep 4, 2026
FDA approves Zanvastro for Alexander disease, the first treatment targeting the root cause of this rare neurological disorder.
© 2026 The Next Trillions. All rights reserved.
Theme by mlggdg.